Researchers Awarded Merkin Prize for Cochlear Innovation

Blake Wilson and a team of researchers received the prestigious award for their work on cochlear implant technology.

Updated on Sept. 21, 2026 in Biotech

A modern cochlear implant processor and a neural sensor resting on a clean laboratory surface. — Blake Wilson and his team were awarded the Merkin Prize in Biomedical Technology for their development of continuous interleaved sampling for cochlear implants. AI Illustration. Upload story photo >

Live Poll

Should the federal government prioritize funding for long-term scientific research projects?

Blake Wilson and four other researchers have been awarded the Merkin Prize in Biomedical Technology, which comes with a $400,000 cash award. The honor recognizes the team for their contributions to technology that improves human health.

Why it matters

The prize highlights advancements in cochlear implants, which currently assist more than 1 million people by conveying electrical signals directly to the brain. This recognition celebrates the development of continuous interleaved sampling, a method that transformed these devices into clinical tools.

The Merkin Prize carries a $400,000 cash award for recipients. Cochlear implants, enabled by continuous interleaved sampling, currently support over 1 million people worldwide.

The players

Blake Wilson

He is a researcher who conducted two decades of study into cochlear implants at RTI International.

Broad Institute of MIT and Harvard

This is a prominent research organization that administers the annual Merkin Prize.

National Institutes of Health

This is a United States government agency that provided funding for 20 years of cochlear implant research.

The details

Researchers developed the continuous interleaved sampling method in the early 1990s, allowing cochlear implants to move from experimental stages to widespread clinical use. The work builds upon two decades of research funded by the National Institutes of Health, which Wilson conducted at RTI International.

The 1970s marked a time when cochlear implants were considered a fool's dream.
Researchers developed continuous interleaved sampling in the early 1990s.
The Merkin Prize was first awarded in 2023.
The researchers were awarded the Merkin Prize in September 2026.

Deeper Dive

The awarding of this prize continues the annual recognition of biomedical breakthroughs established by the 2023 inaugural Merkin Prize.

This development highlights the ongoing evolution of assistive medical devices that improve hearing for over 1 million users. The continued funding and recognition of this technology ensure that advanced treatment options remain a focus for clinical healthcare providers.

The takeaway

The evolution of cochlear implants from an experimental dream to a clinical reality underscores the vital role of sustained government-funded research. This milestone serves as a reminder that long-term investment in scientific inquiry is essential for delivering life-changing medical outcomes.